On Oct 24, major Wall Street analysts update their ratings for $Lam Research (LRCX.US)$, with price targets ranging from $76 to $100.
Morgan Stanley analyst Joseph Moore maintains with a hold rating, and adjusts the target price from $92.9 to $76.
Wells Fargo analyst Joseph Quatrochi maintains with a hold rating, and maintains the target price at $85.
Evercore analyst Mark Lipacis maintains with a buy rating, and adjusts the target price from $113 to $95.
TD Cowen analyst Krish Sankar maintains with a buy rating, and adjusts the target price from $105 to $100.
Needham analyst Charles Shi maintains with a buy rating, and adjusts the target price from $113 to $100.
Furthermore, according to the comprehensive report, the opinions of $Lam Research (LRCX.US)$'s main analysts recently are as follows:
Lam Research's recent performance was mostly aligned with expectations, balancing decreases in China with robustness in other areas. However, this does not address more substantial, enduring uncertainties. It is anticipated that Lam will surpass the growth of the wafer fab equipment sector in the forthcoming year, yet a moderate stance on the broader market is maintained.
Lam Research's modest outperformance and slight raise in expectations were received more positively than anticipated, while near-term concerns regarding China may have been mitigated to some extent. The stock might continue to fluctuate within a certain price range until there is greater visibility on the restrictions in China and the pace of growth for the 2025 wafer fabrication equipment.
Here are the latest investment ratings and price targets for $Lam Research (LRCX.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月24日，多家華爾街大行更新了$泛林集團 (LRCX.US)$的評級，目標價介於76美元至100美元。
摩根士丹利分析師Joseph Moore維持持有評級，並將目標價從92.9美元下調至76美元。
富國集團分析師Joseph Quatrochi維持持有評級，維持目標價85美元。
Evercore分析師Mark Lipacis維持買入評級，並將目標價從113美元下調至95美元。
TD Cowen分析師Krish Sankar維持買入評級，並將目標價從105美元下調至100美元。
Needham分析師Charles Shi維持買入評級，並將目標價從113美元下調至100美元。
此外，綜合報道，$泛林集團 (LRCX.US)$近期主要分析師觀點如下：
拉姆研究最近的表現大多與預期相一致，在中國市場下滑的情況下，其他地區表現堅挺。然而，這並未解決更爲重大、持久的不確定性。預計拉姆將在未來一年內超過硅片製造-半導體板塊的增長，但對更廣泛市場的持謹慎態度。
拉姆研究的適度超越和稍微提高的預期獲得了比預期更積極的回應，然而對中國的近期擔憂可能已在一定程度上得到緩解。股票可能在一定價格區間內繼續波動，直到對中國限制及2025年硅片製造設備增長速度有更明確的了解。
以下爲今日8位分析師對$泛林集團 (LRCX.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
